2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $13B | $14B | $14B | $15B | $16B |
Cost of Revenue | $11B | $11B | $12B | $12B | $13B |
Gross Profit | $2.2B | $2.8B | $2.7B | $2.7B | $2.9B |
Gross Profit % | 17% | 20% | 19% | 18% | 19% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $1B | $1.5B | $1.4B | $1.5B | $1.6B |
Dep. & Amort. | $223M | $212M | $219M | $211M | $242M |
Def. Tax | $0 | -$59M | $0 | $0 | $0 |
Stock Comp. | $71M | $85M | $82M | $85M | $91M |
Chg. in WC | $31M | $161M | -$844M | -$463M | -$231M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $5.6B | $5.3B | $4.3B | $4.4B | $4.3B |
ST Investments | $0 | $0 | $61M | $0 | $0 |
Cash & ST Inv. | $5.6B | $5.3B | $4.3B | $4.4B | $4.3B |
Receivables | $7.8B | $8.5B | $8.1B | $8.7B | $9.2B |
Inventory | $1.1B | $1.2B | $1.3B | $1.3B | $0 |
Omnicom reported Q1 2025 organic revenue growth of 3.4%, in line with expectations, with strong performance in media, advertising, and precision marketing; adjusted EBITDA margin was 13.8%, and non-GAAP adjusted EPS was $1.70, up 1.8% year-over-year.
The company expanded its full-year 2025 organic growth guidance range to 2.5%-4.5% (from a prior lower bound), citing macroeconomic uncertainty, but maintained its adjusted EBITDA margin guidance at 10 basis points above the 15.5% achieved in 2024.
Progress continues on the proposed acquisition of Interpublic (IPG): shareholder approval has been received, regulatory approval has been granted in 5 of 18 jurisdictions (including China), and integration planning is underway targeting $750 million in run-rate cost synergies post-closing, expected in the second half of 2025.
Segment performance highlights: Media and advertising grew 7%, precision marketing grew 6%, while public relations declined 5%, healthcare was down 3%, and branding/retail commerce declined 10% due to market uncertainty and reduced M&A activity; U.S. organic growth was 5%, Latin America 15%.
Management emphasized a strong balance sheet, continued share repurchases (targeting ~$600 million for FY25), robust free cash flow, and ongoing investment in AI-driven platforms (OmniAI) to drive operational efficiency and client outcomes; no significant client losses or account risks have materialized related to the IPG transaction.